Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.291EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.349EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.314EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.132EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.86 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.7 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.12 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.7.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.390EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.319EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.572EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.397EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.3 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used